<DOC>
	<DOCNO>NCT02661048</DOCNO>
	<brief_summary>The objective clinical investigation evaluate safety efficacy CyberHeart System patient refractory ventricular tachycardia ( VT ) . The ablation perform CyberHeart System target anatomical site clinically present VT , use standard radiosurgery technique . Cardiac radiosurgery minimally-non invasive , painless , procedure . Tissue ablation accomplish precisely .</brief_summary>
	<brief_title>CyberHeart 's Cardiac Arrhythmia Ablation Treatment : Patients With Refractory Ventricular Tachycardia/Fibrillation</brief_title>
	<detailed_description>This study two center , non-randomized , open label clinical trial . The objective clinical investigation evaluate safety efficacy CyberHeart System patient refractory ventricular tachycardia . The clinical hypothesis study CyberHeart treatment approach safe study show inferior current treatment option , may lead survival benefit improve quality life . The ablation perform CyberHeart System target anatomical site clinically present VT . The application site determine morphological criterion 12 lead ECG along anatomical data MRI CT scan . Ablation perform designate location intention produce substrate modification . The Study enroll maximum 10 patient .</detailed_description>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<mesh_term>Arrhythmias , Cardiac</mesh_term>
	<criteria>Presence implantable cardioverterdefibrillator ( ICD ) Patients ischemic nonischemic cardiomyopathy recurrent symptomatic VT induce ICD shock ( ) follow catheter ablation and/or antiarrhythmic drug ( AAD ) therapy . 60 year age great . Left ventricular ejection fraction &gt; 20 % . Failure ineligible catheter ablation . Unable unwilling provide inform consent Patients idiopathic VT Women pregnant Prior radiation therapy thorax Active ischemia reversible cause VT Active noncardiovascular illness systemic infection Presence thrombus right atrium right ventricle preprocedure echocardiogram Cardiogenic shock NYHA ( New York Heart Association ) Class IV Heart Failure . Presence incessant VT hemodynamically unstable . Acute heart failure exacerbation . Revascularization past 90 day . Other disease process likely limit survival le 12 month</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>